| 3/22/2024 | 300693000000 | PLACEBOAS AND BLIND (OR DOUBLE BLIND) CLINICAL TRIAL KITS FOR USE IN RECOGNIZED CLINICAL TRIALS (IN MEASURED DOSES) (ROW4 NOE-101 2.5 MG BC BKLT LBLD NOE-TSC-201) | 7 | SET | 920 | N/A | SMO TU LOJİSTİK VE AMBALAJ SANAYİ VE TİCARET LİMİTED ŞİRKETİ |
| 3/18/2024 | 300693000000 | PLACEBOAS AND BLIND (OR DOUBLE BLIND) CLINICAL TRIAL KITS (IN MEASURED DOSES) FOR USE IN RECOGNIZED CLINICAL TRIALS (ONE SINGLE-USE VIAL OF HLX10 OR PLACEBO CONCENTRATE FOR SOLUTION FOR INFUSION CONCENTRATION 10MG/ML VOLUME:10MLFOR INTRAVEN) | 79 | SET | 683 | N/A | PSI CRO FARMA DESTEK HİZMETLERİ LİMİTED ŞİRKETİ |
| 3/12/2024 | 300693000000 | PLACEBOAS AND BLIND (OR DOUBLE BLIND) CLINICAL TRIAL KITS (IN MEASURED DOSES) FOR USE IN RECOGNIZED CLINICAL TRIALS (KIT WITH 1 VIAL OF NAMILUMAB (KIN-1901) 150MG/ML PLACEBO) | 4 | SET | 489 | N/A | FORTREA TURKEY KLİNİK ARAŞTIRMA LİMİTED ŞİRKETİ |
| 3/4/2024 | 300693000000 | PLACEBOAS AND BLIND (OR DOUBLE BLIND) CLINICAL TRIAL KITS (IN MEASURED DOSES) FOR USE IN RECOGNIZED CLINICAL TRIALS (LABELLED BOTTLE CONTAINING 34X PLACEBO TO MATCH A4250 200MCG OR 600 MCG CAPSULE (SIZE 0) FOR PROTOCOL A4250-01 1 ) | 200 | SET | 19721 | N/A | SMO TU LOJİSTİK VE AMBALAJ SANAYİ VE TİCARET LİMİTED ŞİRKETİ |
| 3/22/2024 | 300693000000 | PLACEBOAS AND BLINDED (OR DOUBLE-BLIND) CLINICAL TRIAL KITS (IN MEASURED DOSES) FOR USE IN RECOGNIZED CLINICAL TRIALS (ROW4 NOE-101 1.5MG BC BKLT LBLD NOE-TSC-201) | 5 | SET | 529 | N/A | SMO TU LOJİSTİK VE AMBALAJ SANAYİ VE TİCARET LİMİTED ŞİRKETİ |
| 3/1/2024 | 300693000000 | PLACEBOAS AND BLIND (OR DOUBLE-BLIND) CLINICAL TRIAL KITS (IN MEASURED DOSES) FOR USE IN RECOGNIZED CLINICAL TRIALS (KIT FOR PTG-300-11 FG CONTAINING RUSFERTIDE 30MG OR MATCHING PLACEBO) | 98 | SET | 8428 | N/A | SMO TU LOJİSTİK VE AMBALAJ SANAYİ VE TİCARET LİMİTED ŞİRKETİ |
| 3/18/2024 | 300693000000 | PLACEBOAS AND BLIND (OR DOUBLE BLIND) CLINICAL TRIAL KITS (IN MEASURED DOSES) FOR USE IN RECOGNIZED CLINICAL TRIALS (KIT WITH 1 VIAL OF NAMILUMAB (KIN-1901) 150MG/ML PLACEBO) | 3 | SET | 443 | N/A | FORTREA TURKEY KLİNİK ARAŞTIRMA LİMİTED ŞİRKETİ |
| 3/25/2024 | 300693000000 | PLACEBOAS AND BLIND (OR DOUBLE BLIND) CLINICAL TRIAL KITS (IN MEASURED DOSES) FOR USE IN RECOGNIZED CLINICAL TRIALS (LABELLED BOTTLE CONTAINING AZD5305 20 MG TABLET X30 OR LABELLED BOTTLE CONTAINING PLACEBO TO MATCH AZD5305 20MG TABLET 30) | 200 | SET | 22712 | N/A | SMO TU LOJİSTİK VE AMBALAJ SANAYİ VE TİCARET LİMİTED ŞİRKETİ |
| 3/26/2024 | 300693000000 | PLACEBOAS AND BLIND (OR DOUBLE-BLIND) CLINICAL TRIAL KITS (IN MEASURED DOSES) FOR USE IN RECOGNIZED CLINICAL TRIALS (KIT FOR PTG-300-11 FG CONTAINING RUSFERTIDE 30MG OR MATCHING PLACEBO) | 70 | SET | 6122 | N/A | SMO TU LOJİSTİK VE AMBALAJ SANAYİ VE TİCARET LİMİTED ŞİRKETİ |
| 3/6/2024 | 300693000000 | PLACEBOAS AND BLIND (OR DOUBLE BLIND) CLINICAL TRIAL KITS (IN MEASURED DOSES) FOR USE IN RECOGNIZED CLINICAL TRIALS (KIT WITH 1 VIAL OF NAMILUMAB (KIN-1901) 150MG/ML PLACEBO) | 2 | SET | 407 | N/A | FORTREA TURKEY KLİNİK ARAŞTIRMA LİMİTED ŞİRKETİ |